期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | npj Digital Medicine LetPub Score 8.3
50 ratings
Rate
Reputation 9.8 Influence 7.4 Speed 7.0 | ||||||||||||||||||||||||||||
期刊簡稱 | NPJ DIGIT MED | ||||||||||||||||||||||||||||
ISSN | 2398-6352 | ||||||||||||||||||||||||||||
h-index | N.A. | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 3.20%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | https://www.nature.com/npjdigitalmed/ | ||||||||||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||||||
出版商 | NATURE RESEARCH | ||||||||||||||||||||||||||||
主題領域 | Multiple | ||||||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||||||
發行頻率 | |||||||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||||||
每年文章數 | 212每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 99.43% | ||||||||||||||||||||||||||||
OA Related Info | APC: Yes( GBP2790; USD3790; EUR3090; ) APC waiver:Check Notes Other charges: No Keywords: virtual healthcare、digital technologies、mobile technologies、medical sensor development Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2398-6352%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 15 Weeks | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[npj Digital Medicine] 的評論 | 撰寫評論 |
作者: Lissajous 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2024-04-22 15:06:06 評論於 First submitted to the Nature subsidiary journal, rejected in 4 days, suggested to transfer to Communications Medicine (a new journal, not yet Impact Factor). Resubmitted to NC, rejected in 10 days, suggested to transfer to npj Digital Medicine, transferred directly through the transfer link, rejected in 4 days, given an Appeal Request opportunity, but probably not useful(0) 讚! | Lissajous |
作者: Ethanol 領域: 医学 審稿時間: 6.0 month(s) 結果: 拒稿 撰寫評論 |
2023-06-13 19:02:33 評論於 After submission, three rounds of revision comments were given, one major revision and two minor revisions. The opinions of the two external reviewers were very positive. However, in the third round, they suddenly raised concerns about how to choose between fixed and random effects in the meta-analysis method. Following the Cochrane guidelines, the analysis was redone, and the results under both modes were consistent. But the other party did not accept it and chose to reject the submission. If that's the case, then all meta-analysis methods published by the journal are problematic and should be retracted. The editorial team is very unprofessional in handling this and took 6 months to reject it. Besides this methodological issue, they also claimed there were problems with novelty. If that was the case, why didn't they reject it in the first round? Why wait for 6 months and invite three rounds of revision? I really can't understand.(1) 讚! | Ethanol |
作者: hugo 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-05 10:50:15 評論於 It will take more than a month to submit for review? So slow?(0) 讚! | hugo |
作者: Kyro 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-06-17 06:17:41 評論於 Supplement to the previous content: 2022.06.02 Accepted in principle but with some minor modifications allowed + submission of editable files. 2022.06.10 Submission. 2022.06.16 Official acceptance. The work is about machine learning prediction of Alzheimer's disease in the elderly. There were three reviewers in the first round, with two providing many suggestions and raising some questions. One reviewer leaned towards rejection, stating that the title might be exaggerating the work. After adding two additional experiments, both reviewers agreed to accept the paper before the second round of review. The overall quality of the review was very high, and the suggestions made by the three reviewers were very pertinent, greatly improving the article itself.(0) 讚! | Kyro |
作者: Kyro 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2022-06-04 07:21:38 評論於 2021.12.18 Submission 2022.01.25 Under Review 2022.02.23 First Round of Revision 2022.04.22 First Round of Revision Returned 2022.06.02 Accepted(23) 讚! | Kyro |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us